Insider Transactions in Q3 2023 at Relay Therapeutics, Inc. (RLAY)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2023
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
648
-0.27%
|
$5,184
$8.38 P/Share
|
|
Sep 27
2023
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
244
-0.08%
|
$1,952
$8.38 P/Share
|
|
Sep 27
2023
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
294
-0.2%
|
$2,352
$8.38 P/Share
|
|
Sep 27
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
294
-0.22%
|
$2,352
$8.38 P/Share
|
|
Jul 28
2023
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,693
-1.15%
|
$18,623
$11.8 P/Share
|
|
Jul 28
2023
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
1,352
-0.42%
|
$14,872
$11.8 P/Share
|
|
Jul 28
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,628
-1.22%
|
$17,908
$11.8 P/Share
|
|
Jul 28
2023
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
2,683
-1.12%
|
$29,513
$11.8 P/Share
|